lol, now that is hysterical Hoskuld!
It is my obligation to challenge MIsslings statements / actions as a shareholder!
Where did you get that impression? I am challenging Missling's integrity and truthfulness to be believable and hold him to his words. The science always "speaks for itself" in breakthrough biotech especially addressing huge unmet needs. Thats all I need to hear!!
I also found it very telling and fairly obvious that since the entire platform was seemingly stalled out this year, but considering the potential of becomming a commercial pharma company, that there was not even one new hire approaching such a binary event. So I covered all of my avxl shares with calls, in tandem with the latest short attack, plus zero share price run up into anticipation of a good outcome.
So , I'm glad you mentioned sell as that is another of my "options".
If you back check my posts for the past few years, I do sell calls on a percentage of my avxl holdings, and I usually use those georgejjl posts (as he seems to have a finger on the heartbeat of enthusiasm here) as a prompt. Seriously, it worked like a charm over 90% of the time, keeping the premium or waiting a short while if the shares ever were taken to buy them back. Hey, those Novemebr calls were packing very strong premiums right up to the close before the CHMP feedback. I have now sold 1/2 of my avxl position and moved them over to anvs. I believe this space of treating Alzheimers and CNS disease at its earliest stages and addressing the root cause "includes" a few legit comapies / sciences.
It will be interesting how this all plays out and I hope to get the chance to start selling avxl calls again although my core position is a bit smaller.
ps - you sound a bit disgruntled - MIssling do that to you?
Market Data 
Markets 
AI
